Login
$XLAB
$3.17 +$0.09 (2.92%) Close

Balance sheet

In millions of USD, except per-share amounts
Q4 FY2026
As of Jun 30, 2026
ASSETS
Current Assets
Cash and cash equivalents
U.S. Dollar Coin
Accounts receivable, net
Advance to suppliers
Refundable deposits receivable
Total Current Assets
Non-Current Assets
Deferred offering costs
Equipment, net
Total Non-Current Assets
Total Assets
LIABILITIES AND SHAREHOLDERS’ DEFICIT
Current Liabilities
Accounts payable
Simple agreements for future equity
Contract liabilities
Refundable deposits payable
Other current liabilities
Total Current Liabilities
Total Liabilities
Shareholders’ Deficit
Common stock (US$0.01 par value per share; 1,500 shares authorized; 1,500 shares issued and outstanding as of June 30, 2025)
Common Stock Class A
Common Stock Class B
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
Total Liabilities and Shareholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support